Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Cabergoline
Trade Name
Dostinex
Manufacturer
Pharmacia &Upjhon
Drug Image
Dostinex
Risk Category
B
  • Controlled studies done on animals in reproduction do not indicate risk to the fetus.
  • No adequate and well-controlled studies done on pregnant women.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • dopamine agonist used for treatment of hyperprolactinemia.
  • Fetal Risk
    Fetal Risk
  • Crosses the placenta in animals, unknown in human.
  • At maternal toxic doses the drug is fetotoxic in animals causing embryo-fetal loss.
  • Congenital anomalies have been reported in only one animal study when very high doses were administered.
  • Although no evidence of fetal adverse effects in the limited human data it is not recommended for use during pregnancy and advised to discontinue the drug once regular ovulatory cycles have been acheived and before one month of intended pregnancy.
  • Breast Feeding
    Breast Feeding
  • Unknown passage into milk.
  • Should not be used because it suppresses lactation.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     8   +   4    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year